Huaying Morning Brief | Q2 Earnings Season Kicks Off! U.S. Stocks Rose Over 2% Last Week; Hong Kong Stock Market Suspended Today Due to Typhoon 'Talim'

This week, major companies including Tesla and Netflix will release their earnings reports. On Friday, popular Chinese概念股 broadly declined: the Nasdaq Golden Dragon China Index fell 2.17%, yet rose 6.64% for the week. On Tuesday (July 18), Bank of America, Morgan Stanley, and Charles Schwab will release earnings before the U.S. market opens; on Wednesday, ASML, Goldman Sachs, and UBS Group will release earnings before the U.S. market opens, while Tesla, Netflix, and Zions Bancorporation will release earnings after the U.S. market closes; on Thursday, TSMC will release earnings before the U.S. market opens. Hong Kong Stock Market Suspended Due to Typhoon 'Talim' Last Friday, the Hang Seng Index closed up 0.33%, rising over 1,000 points for the week. Auto parts stocks stood out: Zhejiang Shibo (01057.HK) surged over 40% for the week and over 74% for the month; Nexteer Automotive (01316.HK) rose over 17% for the week and over 30% for the month; newly listed Yaoshi Bang (09885.HK) jumped over 36% for the week—analysts suggest it may be included in the Stock Connect program by early September. Hot weather provided a boost: Dongyue Group (00189.HK), a leading refrigerant manufacturer, rose over 23% for the week. This week, China Evergrande and Kimbee Holdings will release earnings. Due to Typhoon 'Talim', the Hong Kong Exchanges and Clearing (HKEX) suspended trading for all Hong Kong equities (including Stock Connect) and derivatives markets for the entire day. New Listings in Hong Kong and U.S. Markets Hong Kong: 1) Xin Chuan Planning (01284.HK) had originally planned to list today but postponed its listing due to the typhoon-induced suspension of Hong Kong trading. Its Hong Kong public offering was oversubscribed 44.2 times. During Friday’s dark pool trading, its share price surged as much as 19% on some brokers’ platforms and closed up 2.17%, generating HK$100 profit per lot. 2) Zhong’an Smart Living (02271.HK) announced it will issue approximately 127 million shares at HK$1.18 per share, with 2,000 shares per lot. The public offering was oversubscribed 1.84 times, with a 50% allotment rate for one-lot applicants. Listing is expected on July 18. U.S. Markets: 1) Among three stocks that successfully listed last Friday, Apogee Therapeutics (APGE), a biotech firm focused on inflammatory diseases, performed best—surging over 28% intraday and closing up 24.88% at $21.23, with a market capitalization exceeding $1 billion. Nabors Energy Transition Corp. II (NETDU), a special purpose acquisition company (SPAC), closed up 1.1%. Sagimet Biosciences Inc. (SGMT), a biotech firm targeting liver disease and cancer, edged down 0.31%. 2) BioNexus Gene Lab Corp. (BGLC), a supplier of raw materials and blood testing services, is scheduled to list tonight. Additionally, ODD, SRM, WRNT, FTEL, and several other companies are expected to list later this week. Disclaimer: This article does not constitute any investment advice nor is it tailored to the specific investment objectives, financial situation, or individual needs of any particular investor.

Huaying Morning Brief | U.S. Stock Indices Diverged—Dow Jones Extended Gains to Nine Consecutive Days; Hong Kong New Listings Soared, with Multiple Stocks Doubling in Short Term

Pharmaceuticals, infrastructure, and insurance sectors advanced: Johnson & Johnson rose over 6%, Freeport-McMoRan climbed 3%, Eli Lilly and Merck rose over 2%. Abbott Laboratories (ABT), whose Q2 earnings and revenue exceeded expectations, closed up 4.2%. Zions Bancorporation (ZION), a regional bank whose Q2 earnings beat forecasts, closed nearly 10% higher. Most popular Chinese概念股 declined: the Nasdaq Golden Dragon China Index fell 0.62%. iQIYI, Tencent Music, and NIO each dropped over 3%; Bilibili and Weibo each fell over 2%. European Stocks Rose Broadly; U.S. Wheat Futures Jumped 11% in Three Days European equities rallied broadly on Thursday, supported by healthcare stocks. The pan-European index rose for the third consecutive day, as did indices in the UK, France, and Italy. Oil prices edged higher—the U.S. and Brent crude benchmarks briefly rose over 1%, aided by declining U.S. crude inventories and robust Chinese crude imports. Gold retreated from its six-week high, trading near $1,970. U.S. wheat futures surged then pulled back—rising over 11% in three days following Russia’s announcement to suspend implementation of the Black Sea Grain Initiative. India imposed a ban on rice exports, reigniting concerns about global food security. Hong Kong New Listings Soared—Multiple Stocks Surged in Short Term The Hang Seng Index fell 0.13% on Thursday. Today, it opened slightly lower but turned positive at one point. Speculative enthusiasm for new listings flared again: Juxing Legendary surged 60% over two days, then jumped over 9% shortly after opening today—Jay Chou’s concert trended on social media. Yaoshi Bang has roughly doubled in value this month. Zhengwei Group hit a new all-time high—up over 120% since its January listing. Xin Chuan Planning surged over 9% shortly after opening today, gaining 30% over four days. Canggang Railway reached another all-time high—up 3.3-fold since March. Guangdong Transport rose over 70% since June, with expected interim attributable net profit of no less than RMB 120 million. New Listings in Hong Kong and U.S. Markets Hong Kong: Recently, Zhonggang Communications submitted its IPO prospectus to the HKEX, planning to list on the Main Board. The company specializes in telecom infrastructure services. By revenue, it ranked third among all telecom network infrastructure construction and maintenance service providers in Jiangxi Province in 2021, holding a market share of approximately 3.7%. U.S. Markets: 1) ODD—the parent company of Israel’s fast-growing beauty brand Il Makiage—rose 35.8% on its first trading day (Wednesday) and gained over 10% again yesterday, closing up over 5%. 2) Turnstone Biologics Corp. (TSBX), a biotechnology company, is expected to list tonight. BioNexus Gene Lab Corp. (BGLC), a supplier of raw materials and blood testing services, has postponed its listing once again.

BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk

Jul 31, 2026

BioNexus Gene Lab Corp (BGLC) received a risk assessment score of 2.70 among 384 biotech companies, highlighting high volatility with a beta of 2.20 and a 78% maximum drawdown.

TradingKey

2026-05-12

BioNexus Gene Lab Corp (BGLC)

2026-06-18

BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates

2026-06-18

BioNexus Gene Lab Corp (BGLC) Institutional Confidence

2026-06-18

BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

2026-06-18

BioNexus Gene Lab Corp Announces 10-to-1 Merger Stock Split